• Yasmani Grandal Busted For PED Usage

    Posted by on November 7th, 2012 · Comments (0)

    Via the Padres site -

    Yasmani Grandal, who took over as the Padres’ starting catcher in the second half of the season, has been suspended for 50 games without pay by the Office of the Commissioner of Baseball after testing positive for testosterone, a violation of Major League Baseball’s Joint Drug Prevention and Treatment Program.

    Grandal’s suspension will be effective at the start of the 2013 season.

    “I apologize to the fans, my teammates, and to the San Diego Padres,” Grandal said in a statement. “I was disappointed to learn of my positive test and under the Joint Drug Program, I am responsible for what I put into my body. I must accept responsibility for my actions and serve my suspension.”

    Grandal, 23, made his Major League debut for the Padres on June 2 and hit .297 with eight home runs and 36 RBIs in 192 at-bats. In his first start, he hit two home runs against the Rockies on June 30.

    “We were disappointed to learn of the suspension of Yasmani Grandal for violating Major League Baseball’s Joint Drug Prevention and Treatment Program. We fully support Major League Baseball’s policy and its efforts to eliminate performance-enhancing drugs from our game. Per the protocol outlined by Major League Baseball’s Collective Bargaining Agreement, we will not comment further on this matter,” the Padres said in a prepared statement.

    Grandal was one of four players the Padres acquired from the Reds last December in the deal that sent pitcher Mat Latos to the Reds. He was a first-round Draft pick in 2010 (12th overall) by the Reds out of the University of Miami.

    Grandal started the season with Triple-A Tucson and hit .323 with six home runs and 35 RBIs in 201 at-bats. He was promoted to the big leagues on June 1 and returned two days later. Grandal later joined the Padres for good on June 30.

    I really wonder how many players are just playing Russian roulette with the testing process…

    No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.